1. Introduction {#sec1}
===============

Polyphenols are comprised of several groups of compounds (e.g., anthocyanins, flavonols, and phenolic acids) and belong to a family of plant secondary metabolites that widely accumulate in plants as well as fruits \[[@B1]\]. The polyphenols extracted from apples (*Malus pumila* Mill., Rosaceae) mainly contain procyanidins (PCs), as well as known proanthocyanidins, leukocyanidins, and condensed tannins, which account for approximately 65% of apple polyphenols (AP) \[[@B2]\]. PC is formed by catechin oligomers composed of (−)-epicatechin and (+)-catechin monomers (MNs) \[[@B3]\]. PC is also found in a variety of fruits, berries, and several medicinal plants or plant components, such as grape (*Vitis vinifera*) seeds \[[@B4]\], bilberry (*Vaccinium myrtillus*) \[[@B5]\], hawthorn (*Crataegus monogyna*) \[[@B6]\], ginkgo (*Ginkgo biloba*) \[[@B7]\], tormentil (genus*Potentilla*) \[[@B8]\], and oak (genus*Quercus*) \[[@B9]\].

It has been reported that several polyphenols including PC show potential benefits to human health, such as antioxidant \[[@B10]\], antitumor \[[@B11]\], anti-inflammatory effects \[[@B12]\], and longevity \[[@B13]\], as well as protective effects on glucose consumption \[[@B14]\]. We have also revealed that apple PC showed antiallergy \[[@B15]\], antitumor \[[@B16]\], and antiobesity effects \[[@B17]\] in a rodent model and longevity effects on *Caenorhabditis elegans* \[[@B2]\]. In this context, PC might be a promising polyphenol that can prevent age-related diseases.

Alzheimer\'s disease (AD) is a typical age-related and progressive neurodegenerative disease with memory impairment in later life. AD is diagnosed by amyloid accumulation, which is observed as a deposition in the hippocampus and cerebral cortex, named a senile plaque, composed of amyloid *β*-proteins (A*β*) \[[@B18]\]. A*β*42, which consists of 42-residues, is observed mainly in the core of senile plaques. The protein forms strong aggregates themselves that are associated with neurotoxicity *in vitro* \[[@B19]\]. Several polyphenols attenuate insoluble A*β* accumulation \[[@B20]--[@B22]\].

This study addressed the anti-neurodegenerative effects of PC and AP by investigating whether PC can prevent the aggregation of A*β*. The results demonstrated that apple PCs suppress A*β* aggregation and cytotoxicity *in vitro* and strongly contribute to neuroprotection in AP.

2. Materials and Methods {#sec2}
========================

2.1. Compounds {#sec2.1}
--------------

The APs were prepared from immature apples (*Malus pumila* Mill. cv. Fuji), and the methods employed for AP preparation were described previously \[[@B2]\]. The PCs (procyanidins, catechin oligomers) accounted for 63.8% of the AP, and the methods used to prepare the PC and monomer fractions were used as described previously \[[@B2]\]. The A*β*42 peptide was purchased from the Peptide Institute.

2.2. Thioflavin-T Fluorescence Assay {#sec2.2}
------------------------------------

The aggregative abilities of A*β*42 were evaluated using the thioflavin-T (Th-T) method as described previously \[[@B22]\]. Various concentrations of test samples were coincubated with A*β*42 (final concentration 20 *μ*M) for 6 to 48-hour at 37°C in 50 mM phosphate buffer (pH 7.4) containing 100 mM NaCl. In the case of posttreatment, A*β*42 (final concentration 20 *μ*M) was preincubated without PC for 48 hours at 37°C, and then various concentrations of polyphenols were added and incubated for 0.5 to 5 hours at room temperature. The incubated samples were stored at −80°C until measurement. Th-T (final concentration 5 *μ*M, Sigma-Aldrich) in 50 mM glycine-NaOH buffer (pH 8.5) was added to the samples and incubated for 30 minutes at room temperature. The measurements were performed on a SPECTRA max GEMINI XS fluorescence microplate reader (Molecular Devices). Fluorescence intensity was measured using 442 nm for excitation and 485 nm for emission. The percentage of A*β* aggregate inhibition was calculated by comparing the fluorescence values of the test samples with those of vehicle solutions with A*β*42.

2.3. Separation of A*β* Precipitation {#sec2.3}
-------------------------------------

Polyphenol samples (100 *μ*g/mL AP, 65 *μ*g/mL PC, and 35 *μ*g/mL MN) were coincubated with A*β*42 (final concentration 20 *μ*M) for 24 hours as described before \[[@B22]\]. A 300 *μ*L aliquot of the reacted samples was centrifuged at 20,000 ×g for 30 minutes at 4°C. The A*β* pellets were dried at room temperature before optical photographs were obtained using an SZX9 microscope (12.5-fold, OLYMPUS). The pellets were resolved in 6 M guanidine-HCl (pH 4.5--7.5, Sigma-Aldrich) and diluted by 15-fold RIPA buffer containing 0.1% sodium dodecyl sulfate (SDS, Sigma-Aldrich). A*β* concentrations were measured using a DC protein assay kit (Bio-Rad Laboratories). The supernatants of the sedimented samples were denatured at 85°C for 2 minutes with EzApply solution (ATTO) containing 1% SDS and 50 mM dithiothreitol before separation by electrophoresis at 25 mA on 20% polyacrylamide gels in Tris-glycine buffer (SDS-PAGE). Soluble A*β* peptides in 5 *μ*L of reacted solutions were detected using Coomassie brilliant blue staining (Quick-CBB, Wako Pure Chemical) according to the manufacturer\'s protocol.

2.4. Estimation of Cell Viability {#sec2.4}
---------------------------------

PC-12 cells (RCB0009, RIKEN BioResource Center) were used as a neural cell model in order to evaluate the cytotoxicity of A*β* peptides \[[@B23]\]. The experimental procedure was a previously described method \[[@B22]\]. Briefly, after the incubation of the PC-12 culture (2 × 10^4^ cells per well) for 16 hours at 37°C, the cells were pretreated for 1 hour with or without various concentrations of filter-sterilized polyphenols, followed by treatment with 1 *μ*M A*β*42 for an additional 36 hours. Then, cells were treated with thiazolyl blue tetrazolium bromide (MTT, final concentration 0.5 mg/mL, Sigma-Aldrich) for 4 hours at 37°C. After solubilization with SDS (Sigma-Aldrich), the rate of formazan formation was evaluated by measuring the absorbance at 570 nm using a VersaMax microplate reader (Molecular Devices). Data are given as percentages of the control values without PC and A*β*42.

2.5. Statistical Analyses {#sec2.5}
-------------------------

All data were presented as the means ± s.e.m. The StatMate III software package was used for all statistical analyses. Differences were analyzed by Student\'s *t*-test, and multiple comparisons between groups were performed with Dunnett\'s test for posthoc analysis. *P* values of \<0.05 or \<0.001 were considered to be statistically significant.

3. Results {#sec3}
==========

3.1. In Vitro Anti-A*β* Aggregative Effects of Procyanidins {#sec3.1}
-----------------------------------------------------------

To examine the effect of PC on A*β* aggregation, we performed thioflavin-T (Th-T) fluorescence assays for A*β*42 ([Figure 1](#fig1){ref-type="fig"}). The PC comprised approximately 65% of the AP, and the remaining approximately 35% was regarded as the monomer fraction (MN) \[[@B2]\]. In the absence of PC, A*β*42 (20 *μ*M) formed Th-T-binding aggregates 48 hours after incubation, whereas the Th-T fluorescence intensity was dramatically decreased in a dose-dependent manner by AP and PC ([Figure 1(a)](#fig1){ref-type="fig"}). In addition, 100 *μ*g/mL AP and 32.5 *μ*g/mL PC completely abrogated A*β* aggregation throughout the incubation period ([Figure 1(a)](#fig1){ref-type="fig"}, ns; not significant compared with 0 hour, *P* \< 0.01), while MN resulted in a limited decrease in the A*β* aggregation ([Figure 1(a)](#fig1){ref-type="fig"}). Since 32.5 *μ*g/mL PC corresponded to 100 *μ*g/mL AP, this result suggests that PCs have approximately 2-fold the anti-A*β* aggregative ability compared to AP. Interestingly, a bioavailable dose of PC (11.5 *μ*g/mL), which had been detected in rat plasma after the oral administration of 1,000 mg AP/kg body weight \[[@B24]\], significantly suppressed A*β* aggregation ([Figure 1(b)](#fig1){ref-type="fig"}). Furthermore, low-dose AP and PC (1.0 and 0.65 *μ*g/mL, resp.) significantly suppressed A*β* aggregation, while 0.35 *μ*g/mL MN did not suppress the aggregation at any time during the incubation period ([Figure 1(c)](#fig1){ref-type="fig"}). These results suggest that apple PC effectively suppressed A*β* aggregation compared to MN, including epicatechins and catechins.

We next analyzed the inhibitory effect of PC on amyloid aggregation using a centrifugation method, to exclude the possibility that exogenous compounds affected Th-T fluorescence intensity \[[@B25]\]. We observed the typical aggregates of A*β* (20 *μ*M) after 48 hours incubation ([Figure 2(a)](#fig2){ref-type="fig"}; vehicle). Treatment with 100 *μ*g/mL AP and 65 *μ*g/mL PC completely diminished the aggregates, while 35 *μ*g/mL MN treatment did not ([Figure 2(a)](#fig2){ref-type="fig"}). We also detected monomeric A*β*42 in the supernatant by SDS-PAGE following 100 *μ*g/mL AP and 65 *μ*g/mL PC treatment ([Figure 2(b)](#fig2){ref-type="fig"}). A protein concentration assay also demonstrated that 100 *μ*g/mL AP and 65 *μ*g/mL PC markedly inhibited A*β* aggregation ([Figure 2(c)](#fig2){ref-type="fig"}). Taken together, PC and AP exhibited strong anti-amyloidogenic ability *in vitro*.

3.2. Dissociative Activity of Procyanidins against A*β* Aggregates {#sec3.2}
------------------------------------------------------------------

To investigate whether the PC can dissolve aggregated A*β*42, we also performed the Th-T assay using a posttreatment protocol. After the incubation of A*β*42 (20 *μ*M) for 48 hours, various concentrations of AP, PC, and MN were added and then were additionally incubated for 30 minutes ([Figure 3(a)](#fig3){ref-type="fig"}). PC effectively dissociated A*β*42 aggregates in a dose-dependent manner (65--650 *μ*g/mL), while AP resulted in limited dissociation ([Figure 3(a)](#fig3){ref-type="fig"}). On the other hand, A*β* disaggregation was not observed after 360 *μ*g/mL MN treatment (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). In addition, AP and PC also significantly dissociated A*β* aggregates at 30 minutes, and the dissociation continued until 5 hours after addition of the compounds ([Figure 3(b)](#fig3){ref-type="fig"}). In contrast, AP and PC (50 *μ*g/mL and 32.5 *μ*g/mL, resp.) failed to dissociate A*β* aggregates (data not shown). This result indicated that AP and PC dissociated A*β* aggregates in a high-concentration manner.

3.3. Neuroprotective Effects of Procyanidins against A*β*42-Induced Toxicity {#sec3.3}
----------------------------------------------------------------------------

A*β*42 plays a pivotal role in the pathogenesis AD because of its potent aggregative ability and neurotoxicity \[[@B26]\]. PC-12 cells were established to measure cellular viability associated with A*β*42 treatment. These cells were used to investigate the neuroprotective effect of PC against A*β*42-induced neurotoxicity using an MTT assay \[[@B27]\]. The A*β*42 (1 *μ*M) induced cytotoxicity (23.7 ± 2.4% viability) in the cells after coincubation for 36 hours ([Figure 4(a)](#fig4){ref-type="fig"}). When PC-12 cells were preincubated with AP or PC for 1 hour and then treated with A*β*42 for 36 hours, AP and PC significantly inhibited cytotoxicity in a dose-dependent manner. In particular, 32.5 *μ*g/mL PC restored cell viability to 101.2 ± 5.6% ([Figure 4(a)](#fig4){ref-type="fig"}). On the other hand, 100 *μ*g/mL AP restored cell viability to 88.0 ± 13.7% ([Figure 4(a)](#fig4){ref-type="fig"}). When the cells were treated with AP or PC alone (without A*β*42) for 36 hours, a beneficial effect on cell viability was observed at concentrations of 32.5 *μ*g/mL PC and 100 *μ*g/mL AP ([Figure 4(b)](#fig4){ref-type="fig"}). These results indicated that apple PC prevented A*β*42-induced cytotoxicity on PC-12 cells.

4. Discussion {#sec4}
=============

Polyphenols extracted from functional plants have been reported to show antiaggregative and anti-neurotoxic properties *in vitro* \[[@B28]\], and it is not clear whether AP has these functions. Polyphenols, however, usually have poor bioavailability, and this is even more marked for macromolecular substances containing PC \[[@B29], [@B30]\]. On the other hand, the long-term administration of several polyphenols effectively prevents AD-like pathologies and memory impairment in a mouse model of AD \[[@B20], [@B31], [@B32]\]. We have also shown that orally silymarin treatment, extracted from milk thistle (*Silybum marianum*), attenuates AD-like phenotypes in a mouse model of AD \[[@B22]\]. Furthermore, a specific Porter method and high-performance liquid chromatography/tandem mass spectrometry identified apple PC oligomers at a concentration of 11.4 *μ*g/mL in rat plasma 2 hours after single intake of high dose 1,000 mg AP/kg body weight \[[@B24]\]. The present study showed that PC inhibited A*β* aggregation and neurotoxicity at an IC~50~ of 4.8 *μ*g/mL and 9.4 *μ*g/mL, respectively (Figures [1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}), suggesting that apple PC is able to prevent amyloidogenesis at least in vessels. Therefore, it might be able to ameliorate AD-like pathologies and memory impairment in a mouse model of AD receiving long-term administration of PC. Further studies are needed to clarify this matter.

In [Figure 1](#fig1){ref-type="fig"}, Th-T analyses on A*β* aggregation indicated that the IC~90~ of AP was 87.8 *μ*g/mL, while the IC~90~ of PC was 24.7 *μ*g/mL, which corresponded to 38.0 *μ*g/mL AP ([Figure 1(a)](#fig1){ref-type="fig"}). Consequently, the inhibitory activity of PC against A*β* aggregation was approximately 2-fold higher than that of AP. Furthermore, the dissociative effect of AP on A*β* was saturated at concentration of 100 *μ*g/mL, while that of PC continued to increase until 240 *μ*g/mL ([Figure 3(a)](#fig3){ref-type="fig"}). These results corresponded to cell viability of MTT assays ([Figure 4](#fig4){ref-type="fig"}), suggesting that PCs have a more potent ability to promote A*β* disaggregation and neuroprotection than whole APs. In contrast, MN showed limited depression of A*β* aggregation. Whole AP and MN may contain factors that counteract the antiaggregative and neuroprotective activity of PC.

Hirohata et al. reported that myricetin, an antioxidative polyphenol, exerted an anti-amyloidogenic effect by reversible binding to the A*β* fibril structure *in vitro* \[[@B33]\]. Furthermore, Kirschner et al. reported that curcumin suppresses A*β* aggregation via hydrogen binding to A*β*42 at Glu^11^-Gly^25^ \[[@B34]\]. Kumar et al. also reported a structural analysis demonstrating that curcumin directly binds to Gln^15^, Glu^22^, and Asp^23^ of A*β*42 \[[@B39]\]. The Gln^15^ to Ile^32^ region is predicted to be an intramolecular *β*-sheet in A*β* assemblies; thus curcumin can disturb A*β* assembly due to binding to A*βin vitro*as well as *in vivo* \[[@B20], [@B26]\]. Apple PC binding to A*β* at position Gln^15^-Ile^32^ might directly inhibit the conformation of A*β*42. Pasinetti et al. reported that grape seed polyphenolic extract including PC interferes with paired helical filament formation by direct physical intercalation with tau molecules \[[@B35]\]. Therefore, apple PC might have a similar suppressive effect on intermolecular aggregation of tau as well as A*β*42. Interestingly, we also observed a brown-colored pellet that formed following treatment of A*β*42 aggregates with PC and AP (data not shown), suggesting that PC could bind to A*β*42 aggregates. On the other hand, treatments with neither vitamin-C (2 mM) nor the potent antioxidative agent, EUK-134 (40 *μ*M), did not suppress the A*β* aggregation (data not shown), thus suggesting that the antiaggregative activity of PC might likely be independent of its antioxidant properties. Although Yatin et al. reported that vitamin-E (VE) does not suppress A*β*42 aggregation \[[@B36]\], Yang et al. revealed that *α*-tocopherol quinone derived from VE inhibits A*β* aggregation in a dose-dependent manner \[[@B37]\]. These findings suggest that the chemical structure of these compounds impacts the inhibition of A*β* aggregation rather than their antioxidative capacity.

In [Figure 4(a)](#fig4){ref-type="fig"}, PC showed potent neuroprotective effects in a dose-dependent fashion, demonstrating that PC can play a role in both A*β*-disaggregation and cellular survival. In addition, the neuroprotective effect of PC was stronger than that of AP as well as MN ([Figure 4(a)](#fig4){ref-type="fig"}), which was consistent with the antiaggregative activity of PC (Figures [1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}), suggesting that PC suppress A*β* aggregation leading to neuroprotection against A*β*42. Interestingly, we also found an additional effect of PC on cell viability analysis. When PC-12 cells were treated with PC (32.5 *μ*g/mL) without A*β*, the percentages of cell viability were enhanced to over 100% ([Figure 4(b)](#fig4){ref-type="fig"}). Furthermore, AP also significantly induced cellular viability at a concentration of 100 *μ*g/mL ([Figure 4(b)](#fig4){ref-type="fig"}). Miura et al. previously reported that treatment with low-dose PC enhanced cell proliferation, while high-dose PC induced apoptosis in melanoma cells \[[@B16]\]. Recently, Choi et al. reported that PC treatment inhibits endogenous histone acetyltransferase, subsequently suppresses cell proliferation, and increases cell death in prostate cancer cells \[[@B38]\]. These results suggest that PC can regulate cell proliferation in a dose-dependent manner. Therefore, apple PC might not only suppress A*β* aggregation but also modify neuronal cell proliferation, thus contributing to the neuroprotective effect against A*β*-induced cytotoxicity.

In conclusion, apple PC acted as a potent suppresser of abnormal A*β* aggregation and a showed protective effect on neuronal survival *in vitro*. Since apple PC is a safe and an inexpensive food factor, it might be promising for long-term treatment. Our study suggests a novel activity of apple PC, further supporting the consideration of their use for either the prevention or treatment of A*β* aggregation associated with neurodegenerative disorders.
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![Procyanidins suppress A*β* aggregation in vitro. (a) Dose-dependent suppression of A**β**42 aggregation by polyphenols as indicated by thioflavin-T (Th-T) analysis. Various concentrations of apple polyphenol (AP), procyanidins (PC), and monomers (MN) were incubated with A**β**42 (final concentration 20 *μ*M) for 48 hours. (Differences from 0 hour (baseline), ns: not significant (*P* \< 0.01)). (b, c) Time-dependent A**β**42 aggregation in the presence of polyphenols as indicated by the Th-T assay. (b) A*β*42 (20 *μ*M) was incubated with AP (18.0 *μ*g/mL), PC (11.5 *μ*g/mL), and MN (6.5 *μ*g/mL). (c) A**β**42 (20 *μ*M) was incubated with AP (1.0 *μ*g/mL), PC (0.65 *μ*g/mL), and MN (0.35 *μ*g/mL). (differences compared to vehicle groups, \**P* \< 0.001 (Dunnett\'s test)). Values are the means ± s.e.m., *n* = 5.](BCRI2011-784698.001){#fig1}

![Procyanidins extinguish A*β* precipitation. (a) Microscopic observation of A*β*42 precipitates by centrifugation in the presence of polyphenols. The aggregates were observed by 12.5-fold magnification. (b) SDS-PAGE analysis of soluble A*β*42 peptide of supernatants in reaction mixtures. Arbitrary density of monomeric A*β*42 bands was calculated in the right column, 5 *μ*L/lane. (c) A*β* concentrations of supernatant and precipitate in the reaction mixtures. AP (100 *μ*g/mL), PC (65 *μ*g/mL), and MN (35 *μ*g/mL) were incubated with A*β*42 (20 *μ*M) for 24 hours and centrifuged to fractionate supernatants and pellets as described in [Section 2](#sec2){ref-type="sec"} (ND: not detected; differences compared to vehicle groups, \*\*\**P* \< 0.001 and \**P* \< 0.05 (Student\'s *t*-test)). Values are the means ± s.e.m., *n* = 3.](BCRI2011-784698.002){#fig2}

![Procyanidins dissolve A*β* aggregates in vitro. (a) Dose-dependent dissociation of A*β*42 aggregates by polyphenols determined using Th-T analysis. Samples were preincubated with A*β*42 for 48 hours (final concentration 20 *μ*M) and then incubated with various concentrations of AP, PC, or MN for an additional 30 minutes. (b) Time-dependent A*β*42 disaggregation in the presence of polyphenols determined by the Th-T assay. Samples were preincubated with A*β*42 (20 *μ*M) for 48 hours and then incubated with AP (360 *μ*g/mL), PC (240 *μ*g/mL), or MN (360 *μ*g/mL). (Compared to vehicle groups, \**P* \< 0.001 (Dunnett\'s test)). Values are the means ± s.e.m., *n* = 3.](BCRI2011-784698.003){#fig3}

![Procyanidins restore viability of PC-12 cells treated with A*β*42. Cells were pretreated with various concentrations of AP, PC and MN for 1 hour, and then, incubated with (a) or without (b) 1 *μ*M A*β*42 for 36 hours. Cell viability was measured by the MTT assay. Values are the means ± s.e.m., *n* = 3. (Compared to the control group (0 *μ*g/mL), \*\*\**P* \< 0.001 and \**P* \< 0.05 (Dunnett\'s test)).](BCRI2011-784698.004){#fig4}
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